Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127903961 | 12790396 | 1 | I | 2015 | 20160923 | 20160928 | 20160928 | EXP | GB-AMGEN-GBRSP2016131108 | AMGEN | 60.00 | YR | A | M | Y | 0.00000 | 20160928 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127903961 | 12790396 | 1 | PS | carfilzomib | CARFILZOMIB | 1 | Unknown | UNK | U | 202714 | UNKNOWN FORMULATION | ||||||||
| 127903961 | 12790396 | 2 | SS | BORTEZOMIB | BORTEZOMIB | 1 | Unknown | UNK | 0 | ||||||||||
| 127903961 | 12790396 | 3 | SS | BORTEZOMIB | BORTEZOMIB | 1 | Unknown | UNK | 0 | ||||||||||
| 127903961 | 12790396 | 4 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | UNK | 0 | ||||||||||
| 127903961 | 12790396 | 5 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | UNK | 0 | ||||||||||
| 127903961 | 12790396 | 6 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | UNK | 0 | ||||||||||
| 127903961 | 12790396 | 7 | SS | LENALIDOMIDE | LENALIDOMIDE | 1 | Unknown | UNK | 0 | ||||||||||
| 127903961 | 12790396 | 8 | SS | LENALIDOMIDE | LENALIDOMIDE | 1 | Unknown | UNK | 0 | ||||||||||
| 127903961 | 12790396 | 9 | SS | MELPHALAN | MELPHALAN | 1 | Unknown | UNK | 0 | ||||||||||
| 127903961 | 12790396 | 10 | SS | POMALIDOMIDE | POMALIDOMIDE | 1 | Unknown | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127903961 | 12790396 | 1 | Plasma cell myeloma |
| 127903961 | 12790396 | 2 | Plasma cell myeloma |
| 127903961 | 12790396 | 4 | Plasma cell myeloma |
| 127903961 | 12790396 | 7 | Plasma cell myeloma |
| 127903961 | 12790396 | 9 | Plasma cell myeloma |
| 127903961 | 12790396 | 10 | Plasma cell myeloma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127903961 | 12790396 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127903961 | 12790396 | Disease progression | |
| 127903961 | 12790396 | Drug ineffective | |
| 127903961 | 12790396 | Liver function test abnormal | |
| 127903961 | 12790396 | Neutropenia | |
| 127903961 | 12790396 | Pyrexia | |
| 127903961 | 12790396 | Thrombocytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127903961 | 12790396 | 1 | 201511 | 0 | ||
| 127903961 | 12790396 | 2 | 2013 | 0 | ||
| 127903961 | 12790396 | 3 | 201512 | 0 | ||
| 127903961 | 12790396 | 4 | 2013 | 0 | ||
| 127903961 | 12790396 | 5 | 201507 | 0 | ||
| 127903961 | 12790396 | 6 | 201512 | 0 | ||
| 127903961 | 12790396 | 7 | 2014 | 0 | ||
| 127903961 | 12790396 | 8 | 201512 | 0 | ||
| 127903961 | 12790396 | 9 | 201504 | 0 | ||
| 127903961 | 12790396 | 10 | 201507 | 0 |